International Business Machines Corp

NYSE: IBM
$204.99
-$4.00 (-1.9%)
Closing Price on November 15, 2024

IBM Articles

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline expectation of more than 7% gains in 2020.
The year 2019 was nothing short of incredible. On top of the bull market now being well over 10 years old, the Dow Jones industrials, S&P 500 and Nasdaq all put in strong gains at the end of the...
Investors have a lot to consider as 2020 gets closer. 24/7 Wall St. has identified seven of the 30 Dow stocks to which value investors and others may flock.
Several of America’s largest companies have posted poor results, based on both their stock prices and financial reports. Boeing stood out as clearly the worst of the list.
One theme that investors love in good times and in bad is dividend investing. One strategy that has been around for years is known as the Dogs of the Dow.
Several of America's largest companies have posted poor results. Some of them are perennial losers, trailing other companies in their sectors for years.
Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as early 2020, if only a few things come to fruition. There does not even have to be a big...
Amazon has officially begun its expected protest of the Department of Defense's award of a $10 billion cloud services contract to Microsoft.
With markets at all-time highs, it's important to consider the winners and losers. In this case, many stocks in the Dow are still holding the index back from even stronger gains.
It's one thing to have won the $10 billion JEDI cloud contract from the Department of Defense, but it's more important to consider how Microsoft might be able to use this over Amazon and AWS as the...
Monday's top analyst upgrades, downgrades and initiations included Amazon.com, Apple, Bank of America, Boeing, Cheniere Energy, Chipotle Mexican Grill, CommScope, IBM, Peloton Interactive, Pinterest...
IBM released its third-quarter financial results after the markets closed on Wednesday. For the most part, analysts seemed to be sidelined on the stock, but they see a light at the end of the tunnel.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
The cloud was supposed to save IBM. Its most recent results for that part of its business are barely mediocre. It is impossible to find a big tech company that has given investors an uglier ride.
Unfortunately, IBM's new businesses and strategic imperatives just are not able to offset the old core businesses fast enough to move the needle for IBM to be considered attractive to investors who...